Concurrent Inhibition of The RAS Pathway and Autophagy As a Treatment Approach for Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is characterized clinically by poor survival and mechanistically by KRAS- and autophagy-dependent growth. We and others previously demonstrated that inhibition ...
Your why may not be what you think it is. by Jonathan Knowles, Tom Hunsaker, Hannah Grove and Alison James Today’s business leaders are under pressure to come up with a corporate purpose, much as they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results